223 related articles for article (PubMed ID: 25149476)
21. Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma.
Zbuk KM; Patocs A; Shealy A; Sylvester H; Miesfeldt S; Eng C
Nat Clin Pract Oncol; 2007 Oct; 4(10):608-12. PubMed ID: 17898811
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features of thyroid nodules with PTEN mutations on preoperative testing.
Quaytman JA; Nikiforov YE; Nikiforova MN; Morariu E
Endocr Relat Cancer; 2022 Sep; 29(9):513-520. PubMed ID: 35723418
[TBL] [Abstract][Full Text] [Related]
23. Germline PTEN mutations in Cowden syndrome-like families.
Marsh DJ; Dahia PL; Caron S; Kum JB; Frayling IM; Tomlinson IP; Hughes KS; Eeles RA; Hodgson SV; Murday VA; Houlston R; Eng C
J Med Genet; 1998 Nov; 35(11):881-5. PubMed ID: 9832031
[TBL] [Abstract][Full Text] [Related]
24. Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.
Lobo GP; Waite KA; Planchon SM; Romigh T; Nassif NT; Eng C
Hum Mol Genet; 2009 Aug; 18(15):2851-62. PubMed ID: 19457929
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer.
Agrawal S; Eng C
Hum Mol Genet; 2006 Mar; 15(5):777-87. PubMed ID: 16436456
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line.
Singh G; Odriozola L; Guan H; Kennedy CR; Chan AM
BMC Cancer; 2011 Nov; 11():490. PubMed ID: 22103913
[TBL] [Abstract][Full Text] [Related]
28. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.
Orloff MS; He X; Peterson C; Chen F; Chen JL; Mester JL; Eng C
Am J Hum Genet; 2013 Jan; 92(1):76-80. PubMed ID: 23246288
[TBL] [Abstract][Full Text] [Related]
29. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.
Burrows N; Resch J; Cowen RL; von Wasielewski R; Hoang-Vu C; West CM; Williams KJ; Brabant G
Endocr Relat Cancer; 2010 Mar; 17(1):61-72. PubMed ID: 19808899
[TBL] [Abstract][Full Text] [Related]
30. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
[TBL] [Abstract][Full Text] [Related]
32. Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.
Yehia L; Niazi F; Ni Y; Ngeow J; Sankunny M; Liu Z; Wei W; Mester JL; Keri RA; Zhang B; Eng C
Am J Hum Genet; 2015 Nov; 97(5):661-76. PubMed ID: 26522472
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer.
Tate G; Suzuki T; Endo Y; Mitsuya T
Cancer Genet Cytogenet; 2008 Jul; 184(1):67-71. PubMed ID: 18558293
[TBL] [Abstract][Full Text] [Related]
34. Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.
Teresi RE; Zbuk KM; Pezzolesi MG; Waite KA; Eng C
Am J Hum Genet; 2007 Oct; 81(4):756-67. PubMed ID: 17847000
[TBL] [Abstract][Full Text] [Related]
35. Utilizing PTEN immunohistochemistry as a screening test for Cowden syndrome.
Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
[TBL] [Abstract][Full Text] [Related]
36. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
[TBL] [Abstract][Full Text] [Related]
37. Role of PTEN, a lipid phosphatase upstream effector of protein kinase B, in epithelial thyroid carcinogenesis.
Eng C
Ann N Y Acad Sci; 2002 Jun; 968():213-21. PubMed ID: 12119278
[TBL] [Abstract][Full Text] [Related]
38. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.
Won HS; Chang ED; Na SJ; Whang IY; Lee DS; You SH; Kim YS; Kim JS
Cancer Res Treat; 2019 Jan; 51(1):402-407. PubMed ID: 29510612
[TBL] [Abstract][Full Text] [Related]
39. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
[TBL] [Abstract][Full Text] [Related]
40. No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma.
Montani M; Schmitt AM; Schmid S; Locher T; Saremaslani P; Heitz PU; Komminoth P; Perren A
Endocr Relat Cancer; 2005 Dec; 12(4):1011-6. PubMed ID: 16322339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]